U.S. FDA approves subcutaneous formulation of ORENCIA® (abatacept)
29 July 2011 | By Bristol-Myers Squibb
ORENCIA® (abatacept) treatment for adults with moderate to severe rheumatoid arthritis (RA)...
List view / Grid view
29 July 2011 | By Bristol-Myers Squibb
ORENCIA® (abatacept) treatment for adults with moderate to severe rheumatoid arthritis (RA)...
29 July 2011 | By Pfizer
The U.S. FDA issued a 90-day extension to the action date for the Company’s sBLA for use of Prevnar 13®...
28 July 2011 | By Sanofi
Sanofi has appointed Dr. David-Alexandre Gros as Chief Strategy Officer, effective September 1, 2011...
27 July 2011 | By Boehringer Ingelheim
The CHMP issued a Positive Opinion recommending the approval of Viramune® (nevirapine)...
27 July 2011 | By Biogen Idec
Biogen Idec has strengthened MS ActiveSource...
27 July 2011 | By Novo Nordisk
Ultra-long-acting insulin degludec, lowers blood glucose levels...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of a new informatics solution to support clinical laboratories serving the emerging fields of translational and personalized medicine.
27 July 2011 | By Teva UK Ltd
We are pleased to announce the launch of generic letrozole film-coated tablets...
27 July 2011 | By Abbott
Launch of Abbott’s ARCHITECT® HIV Ag/Ab Combo assay...
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today introduced a comprehensive range of clinical research and diagnostic products at the annual conference of the American Association for Clinical Chemistry (AACC). From automated sample handling to innovative sample analysis and storage solutions, ThermoFisher provides an integrated approach…
26 July 2011 | By Merck
Merck and Astellas US LLC have entered into an agreement...
25 July 2011 | By The Scott Partnership
22nd Annual International Light Scattering Colloquium announced...
25 July 2011 | By Roche
Roche has been awarded an exclusive contract by the National Health Laboratory Services (NHLS)...
25 July 2011 | By College Hill Ltd
LEUKOCARE AG, announced the signing of a cooperation agreement with Sanofi Pasteur...
22 July 2011 | By kdm communications ltd
Expansion of the CompoZr® Oncology Disease Model portfolio...